Timing of Gluten-free Oats Introduction for Celiac Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how the timing of introducing gluten-free oats affects individuals recently diagnosed with celiac disease. It compares starting gluten-free oats immediately after diagnosis to waiting six months, focusing on gut symptoms, nutrition, and quality of life. Participants will complete questionnaires and attend clinic visits to monitor their progress. This trial suits those diagnosed with celiac disease in the last three months who have not yet removed oats from their diet. As an unphased trial, it provides a unique opportunity to contribute to understanding dietary impacts on celiac disease management.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, it mentions that patients receiving antibiotics or probiotics within a month can still participate, which suggests that some medications may be allowed.
What prior data suggests that gluten-free oats are safe for individuals with celiac disease?
Research has shown that specially made gluten-free oats are safe for people with celiac disease. Studies have found that these oats do not cause additional symptoms or worsen the condition. New findings confirm that adding gluten-free oats to a gluten-free diet does not affect celiac symptoms or the disease itself. Long-term studies suggest that most people with celiac disease can consume moderate amounts of gluten-free oats without issues. This evidence supports that gluten-free oats are generally well-tolerated.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the timing of introducing gluten-free oats as part of a celiac disease diet. Unlike the standard gluten-free diet, which typically eliminates all forms of gluten-containing grains, this trial investigates whether introducing gluten-free oats either early or late after diagnosis can offer additional benefits. The interest lies in understanding if the timing of oats introduction can improve dietary tolerance and nutritional outcomes for those with celiac disease, potentially offering a more flexible and nutritious approach to managing the condition.
What evidence suggests that this trial's treatments could be effective for celiac disease?
Research shows that gluten-free oats are usually safe for most people with celiac disease. This trial will compare two approaches: introducing gluten-free oats early, within 3 months after diagnosis, and introducing them later, at 6 months after diagnosis. Studies have found that these oats do not cause extra symptoms or worsen the condition. Many people can consume moderate amounts of gluten-free oats without adverse reactions. Adding oats can also enhance the nutrition of a gluten-free diet, although some individuals may have concerns. Overall, gluten-free oats are often well-tolerated and could be a beneficial option for managing celiac disease.24567
Who Is on the Research Team?
Jedid-Jah Blom, RD
Principal Investigator
Hamilton Health Sciences Corporation
Are You a Good Fit for This Trial?
This trial is for people who've been recently diagnosed with celiac disease, confirmed by specific blood tests and intestinal biopsies. They should have started a gluten-free diet within the last three months but haven't yet received detailed dietary guidance or removed oats from their diet.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either early or late introduction of gluten-free oats as part of a gluten-free diet
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of symptom control, nutritional status, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Gluten-free Oats
Gluten-free Oats is already approved in European Union, United States, Canada for the following indications:
- Celiac disease management
- Celiac disease management
- Celiac disease management
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor